| CXSL2500370 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2025-05-10 | | Yifan Pharmaceutical (Shanghai) Co Ltd | | | view |
| JYSZ2300051 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | License Renew | 2023-12-05 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
| JYSZ2300050 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | License Renew | 2023-12-05 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
| CXSL2300687 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-10-12 | | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CXSS2300028 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-05-07 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CXSS2300029 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-05-07 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CXSL2300301 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-05-04 | | ChongQing Chenan Biopharmaceutical Co Ltd | | | view |
| CXSL2300300 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-05-04 | | ChongQing Chenan Biopharmaceutical Co Ltd | | | view |
| CXSL2300176 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-03-08 | | Beijing SL Pharmaceutical Co Ltd | | | view |
| CXSL2200557 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2022-11-04 | | Dongguan HEC Biopharmaceutical R&D Co Ltd;Sunshine Lake Pharma Co Ltd | | | view |
| CXSL2200172 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2022-04-18 | | The United Bio-Technology(Hengqin) Co Ltd | | | view |
| JYSB2101182 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | Supplementary Application | 2021-12-10 | | Novo Nordisk A/S | | | view |
| JYSB2101181 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | Supplementary Application | 2021-12-10 | | Novo Nordisk A/S | | | view |
| CYSB2101148 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | Supplementary Application | 2021-08-12 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2101149 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | Supplementary Application | 2021-08-12 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSL2100112 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2021-04-02 | 吉林惠升生物制药有限公司 | Jilin Huisheng Biopharmaceutical Co Ltd | In Review | 2021-04-01 | view |
| JYSB2000682 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | Supplementary Application | 2020-12-30 | 丹麦诺和诺德公司 | Novo Nordisk A/S | In Review | 2020-12-30 | view |
| JYSB2000681 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | Supplementary Application | 2020-12-30 | 丹麦诺和诺德公司 | Novo Nordisk A/S | In Review | 2020-12-30 | view |
| JYSB2000138 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | Supplementary Application | 2020-04-20 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-04-23 | view |
| JYSB2000137 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products | Supplementary Application | 2020-04-20 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-04-23 | view |
